IP Library Granted Patent US 11,655,284
Granted Patent B2
US 11,655,284 · App. 17/848,205 · Granted May 23, 2023

RSV F protein compositions and methods for making same

Inventors: Kurt Swanson (Newton, MA); Philip R. Dormitzer (Weston, MA)
Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
C07K16/1027A61K39/12A61K39/155C07K14/005A61K39/00A61K2039/5252A61K2039/5256A61K2039/5258A61K2039/53A61K2039/55505A61K2039/55555A61K2039/55561A61K2039/55566A61K2039/55572C07K2317/76C07K2319/00C07K2319/21C07K2319/50C07K2319/73C12N2760/18522C12N2760/18534C12N2770/36143
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,655,284
App. No.
17/848,205
Granted
May 23, 2023
Kind
B2
Abstract

The present invention relates to immunogenic compositions comprising RSV F protein, methods for preparing compositions that contain RSV F protein ecto-domain polypeptides, and to certain engineered RSV F proteins and nucleic acids that encode the engineered RSV F proteins. Compositions prepared using the methods can contain RSV F protein ecto-domain polypeptides in a predominant or single desired form and conformation. The invention also relates to methods for inducing an immune response to RSV F.

Claims (9)

1. A polypeptide comprising a first domain and a second domain, wherein

(i) the first domain comprises a respiratory syncytial virus F (RSV F) protein ectodomain, and

(ii) the second domain comprises a trimerizing sequence from bacteriophage T4 fibritin.

2. The polypeptide of claim 1 , wherein the trimerizing sequence comprises the amino acid sequence of SEQ ID NO: 19.

3. The polypeptide of claim 1 , wherein the trimerizing sequence comprises amino acid residues 3-29 of SEQ ID NO: 19.

4. A nucleic acid encoding the polypeptide of claim 1 .

5. A vector comprising the nucleic acid of claim 4 .

6. A host cell comprising the vector of claim 5 .

7. A method of making a polypeptide comprising a first domain and a second domain, wherein the first domain comprises a respiratory syncytial virus F (RSV F) protein ectodomain, and the second domain comprises a trimerizing sequence from bacteriophage T4 fibritin, the method comprising: culturing the host cell of claim 6 and recovering the polypeptide from a culture media.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2022
From: SWANSON, KURT; DORMITZER, PHILIP R.
To: NOVARTIS VACCINES & DIAGNOSTICS, INC.
Reel/Frame 060321/0286 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2022
From: CHIRON CORPORATION
To: NOVARTIS VACCINES & DIAGNOSTICS, INC.
Reel/Frame 060321/0344 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2022
From: NOVARTIS VACCINES & DIAGNOSTICS, INC.
To: NOVARTIS AG
Reel/Frame 060321/0398 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2022
From: NOVARTIS AG
To: GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 060321/0614 →